title: 25-hydroxyvitamin D Levels and Coronary Heart Disease Risk Reclassification in Hypertension--Is it worth the "hype"?
authors.affiliation: Ciccarone Center for The Prevention of Heart Disease, Johns Hopkins University, Baltimore, MD, USA. Electronic address: edonnell@jhmi.edu.
authors.forename: Erin D
authors.initials: ED
authors.lastname: Michos
authors.affiliation: Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
authors.forename: Pamela L
authors.initials: PL
authors.lastname: Lutsey
mesh_terms: D002112:Calcifediol; D003327:Coronary Disease; D006801:Humans; D006973:Hypertension; D012307:Risk Factors; D014808:Vitamin D Deficiency
chemical_list: D002112:Calcifediol
keywords: Commentary; Coronary heart disease; Hypertension; Risk reclassification; Vitamin D